A probabilistic framework for non-cancer risk assessment

被引:10
作者
Chen, James J. [1 ]
Moon, Hojin [1 ]
Kodell, Ralph L. [1 ]
机构
[1] US FDA, Natl Ctr Toxicol Res, Div Biometry & Risk Assessment, Jefferson, AR 72079 USA
关键词
benchmark dose; distribution of exposure; hierarchical model; interspecies and intraspecies uncertainties; point of departure;
D O I
10.1016/j.yrtph.2006.10.008
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Risk assessment involves an analysis of the relationship between exposure and health related outcomes to derive an allowable exposure level or to estimate a low-dose risk. Acceptable levels of human exposure for non-cancer effects generally are derived by dividing an experimental no-observed-adverse-effect-level or a lower confidence limit benchmark dose by a product of several uncertainty factors. This paper presents a hierarchical modeling framework for a probabilistic approach to non-cancer risk assessment. The hierarchical model integrates the distributions of uncertainty factors and the distribution of the actual exposure level to construct the dose-response model for the proportion of population at risk and the dose-response model for the expected proportion of population at risk for a given exposure distribution. The proposed approach is based on the use of the BMDL (lower confidence limit on the benchmark dose) as a POD (point of departure) for risk assessment of non-cancer effects. Published by Elsevier Inc.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 23 条
[1]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[2]  
[Anonymous], HELP MAN BENCHM DOS
[3]   Model uncertainty and risk estimation for experimental studies of quantal responses [J].
Bailer, AJ ;
Noble, RB ;
Wheeler, MW .
RISK ANALYSIS, 2005, 25 (02) :291-299
[4]   Noncancer risk assessment: A probabilistic alternative to current practice [J].
Baird, SJS ;
Cohen, JT ;
Graham, JD ;
Shlyakhter, AI ;
Evans, JS .
HUMAN AND ECOLOGICAL RISK ASSESSMENT, 1996, 2 (01) :79-102
[5]   REFERENCE DOSE (RFD) - DESCRIPTION AND USE IN HEALTH RISK ASSESSMENTS [J].
BARNES, DG ;
DOURSON, M .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) :471-486
[6]   QUANTITATIVE RISK ASSESSMENT FOR TERATOLOGICAL EFFECTS [J].
CHEN, JJ ;
KODELL, RL .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1989, 84 (408) :966-971
[7]   A NEW METHOD FOR DETERMINING ALLOWABLE DAILY INTAKES [J].
CRUMP, KS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1984, 4 (05) :854-871
[8]   The benchmark dose method - Review of available models, and recommendations for application in health risk assessment [J].
Filipsson, AF ;
Sand, S ;
Nilsson, J ;
Victorin, K .
CRITICAL REVIEWS IN TOXICOLOGY, 2003, 33 (05) :505-542
[9]   Quantitative assessment of exposure to the mycotoxin Ochratoxin A in food [J].
Gauchi, JP ;
Leblanc, JC .
RISK ANALYSIS, 2002, 22 (02) :219-234
[10]   Percentiles of the product of uncertainty factors for establishing probabilistic reference doses [J].
Gaylor, DW ;
Kodell, RL .
RISK ANALYSIS, 2000, 20 (02) :245-250